GALT (STOCKS)
Galectin Therapeutics Inc.
$3.710000
+0.070000 (+1.92%)
Prev close: $3.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joel Lewis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $374.66M
- Employees
- 15
- P/E (TTM)
- -8.47
- P/B (TTM)
- -1.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.